[October 28, 2014]

Research and Markets: Global Sciatica Clinical Trials Therapeutics Review, H2, 2014

Research and Markets (http://www.researchandmarkets.com/research/l66hc7/sciatica_global) has announced the addition of the "Sciatica Global Clinical Trials Review, H2, 2014" report to their offering.

Sciatica Global Clinical Trials Review, H2, 2014" provides data on the Sciatica clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sciatica. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sciatica.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Sciatica Therapeutics Clinical Trials

• Teva Pharmaceutical Industries Limited
• Medtronic, Inc.
• Johnson & Johnson
• Dompe Farmaceutici S.p.A.
• Biogen Idec Inc.
• Leiden University Medical Center
• Nantes University Hospital
• Ziv Medical Center
• Hadassah Medical Organization
• University of California, San Diego
• U.S. Department of Veterans Affairs
• Duke University
• University Hospital, Grenoble
• Johns Hopkins University
• Assistance Publique - Hopitaux de Paris

For more information visit http://www.researchandmarkets.com/research/l66hc7/sciatica_global

[ Back To TMCnet.com's Homepage ]